Navigation Links
Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
Date:11/6/2007

/p>

indicated that a future New Drug Application filing for this product

candidate could be eligible to receive priority review. The company

plans to initiate a Phase II clinical trial in the fourth quarter of

2007.

-- Interim data have been obtained from two single dose studies, one in

healthy volunteers and one in epilepsy patients, of JZP-4, a product

candidate for the treatment of partial epilepsy and bipolar disorder.

The data from both of these studies indicate biological activity in

human epilepsy models. A single dose study of a controlled-release

formulation of JZP-4 is underway, and is expected to complete in the

fourth quarter of 2007. Jazz Pharmaceuticals plans to initiate

Phase II clinical trial activities for JZP-4 by the end of 2007.

-- A second pharmacokinetic study of JZP-7, a product candidate for the

treatment of restless legs syndrome, was initiated in the third quarter

of 2007, and Jazz Pharmaceuticals expects top line results from that

study in the second quarter of 2008.

-- In August 2007, the U.S. Patent and Trademark Office (USPTO) awarded

Jazz Pharmaceuticals a new U.S. patent (No. 7,262,219) titled

"Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate

Salt for the Treatment of Narcolepsy." This Xyrem patent is now listed

in the FDA's Orange Book.

Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss its quarterly results on November 6, 2007 at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.JazzPharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that m
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Antonio, TX (PRWEB) May 21, 2013 ... from the Texas Department of Aging and Disability Services. ... visits and employee interviews, ContinuCare Home Health was ... , The review is part of the Department of ... array of aging and disability services, supports and ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... Annual EB-5 Investment Summit: Dealmakers Conference in Long ... Conference will focus on exploring alternative finance through ... the latest market, legal and economic information, and ... and legal professionals within the EB-5 industry. ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to ... in the Creative Corridor region, is releasing results for ... conference on Thursday, May 23rd at 10:30 a.m. ... , The survey is a critical component ... that attract, nurture and retain people of diverse backgrounds, ...
(Date:5/21/2013)... A paper recently published in the New England ... scientists at the University of Colorado School of Medicine ... fibrosis can be used to identify individuals at risk ... a fairly common variant of the gene for mucin-5B, ... produced by the bronchial tubes. While this variant of ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
... experts say , TUESDAY, Dec. 29 (HealthDay News) -- Winter,s ... but they pose extra hazards for elderly people, experts say. ... adults over age 65 in the United States. Some 1.8 ... departments for falls in 2005, and 15,800 died from their ...
... , ... System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free cosmetic ... ... Health System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free ...
... YORK, Dec. 29 Nutritionist Judy Pentra, of Patients Medical , ... can be a vulnerable time for people trying to lose weight and ... holidays and many resolve to lose the weight in January, however, 70 ... of the biggest problems for busy executives trying to get in shape ...
... N.Y. -- The role of pharmacists hasn,t received much ... care. But national and regional studies show that when ... treatment costs and improve outcomes. A study on diabetic ... and Pharmaceutical Sciences identified cost savings with improvements in ...
... , Michigan Business and Professional Association ... Dec. 29 Eighty-three percent of the owners of small ... care plan as a public option for insurance, according to ... Business and Professional Association (MBPA) and the Michigan ...
... , , SAN JOSE, Calif. , ... 2009 a year of success in advocacy, research support and ... PF is a fatal disease that has no known cause, ... grassroots fundraising efforts in 2009, further advancing the effort to ...
Cached Medicine News:Health News:Caution Can Help Keep Elderly Safe During Winter 2Health News:Patients Medical Warns Against The Manhattan Diet 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 3Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 2Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)...  Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified ... of medical devices and in the domestic sale of diagnostic ... , President and CEO of Vasomedical, Inc. will present ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
... THE WOODLANDS, Texas, Dec. 6, 2011 The US Oncology ... M.D., New York Oncology Hematology , and J. Russell ... discussion with oncologists on value-based reimbursement and its impact on the ... Dec. 13 at 1:00 p.m. ET/ 12 p.m. CT/ 11 a.m. ...
... and AMSTERDAM, Dec. 6, 2011 Agendia, an ... of formalin fixed, paraffin embedded tissue technology applied ... Delivering Agendia,s tests in a paraffin embedded tissue ... the superior science, development and validation found in ...
Cached Medicine Technology:The US Oncology Network to Present Webinar on Value-Based Reimbursement 2Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: